Research Comparison Reference
Semax vs Selank: Peptide Origin and Structure Comparison
A structural reference for two short synthetic heptapeptides that derive from entirely different parent molecules.
Attribute comparison
| Attribute | Semax | Selank |
|---|---|---|
| Compound class | ACTH(4-7)-derived heptapeptide | Tuftsin-derived heptapeptide |
| Peptide or non-peptide | Peptide | Peptide |
| Amino-acid count | 7 | 7 |
| Receptor or pathway classification | Not established | Not established |
| Molecular weight | 813.86 g/mol | 751.87 g/mol |
| Physical form | Lyophilized powder | Lyophilized powder |
| Laboratory research context | Neuropeptide signaling studies | Neuropeptide signaling studies |
| Available from Amino Fuel Labs | Yes | Yes |
Key structural differences
Both molecules are seven residues long and both were developed as synthetic analogs of naturally occurring fragments, but the parent molecules differ. Semax is built from an adrenocorticotropic hormone fragment extended with a proline-glycine-proline tail. Selank is built from the immune-related tetrapeptide tuftsin, extended with the same style of stabilizing tail.
The shared proline-glycine-proline extension is a structural design choice rather than a shared origin, and the two sequences are otherwise unrelated.
Their molecular weights sit within roughly sixty daltons of each other, which is why analytical methods used to distinguish them rely on retention behavior and mass accuracy rather than on size alone.
Published research context
Both peptides have been investigated in research literature originating largely in Russian-language and subsequently indexed international publications. Neither has an approved finished-product status in the United States.
This reference does not describe outcomes, effects, or applications in people.
Frequently asked questions
- Are Semax and Selank the same class of peptide?
- Both are synthetic heptapeptides, but they derive from different parent molecules: Semax from an ACTH fragment and Selank from tuftsin.
- Why do both end in the same three residues?
- Both were designed with a proline-glycine-proline extension, a structural strategy intended to increase resistance to enzymatic degradation.
- Are these approved for human use?
- Not in the United States. Both are supplied by Amino Fuel Labs as research material only and are not for human or veterinary use.
- How are they distinguished analytically?
- By chromatographic retention behavior combined with accurate mass measurement, since the two differ in composition despite similar chain length.
References
- PubMed — Semax research literature — National Library of Medicine
- PubMed — Selank research literature — National Library of Medicine
Related references
Research use only. The information in this library is educational and is not medical advice. Products are not intended to diagnose, treat, cure, or prevent disease and are not for human or veterinary consumption.